Aroa Marketing

Aroa Biosurgery is a soft-tissue regeneration company that develops and manufactures medical devices based on its proprietary extracellular matrix (ECM) technology. The company's core platform, Endoform, is derived from ovine forestomach and provides a natural scaffold for tissue repair and healing by managing protease activity and supporting cell infiltration. Aroa's product portfolio includes the Endoform wound care range, Myriad for complex soft tissue reconstruction, and the Ovitex hernia repair portfolio, which is marketed in partnership with TELA Bio. Headquartered in New Zealand and listed on the ASX, the company is focused on improving clinical outcomes in chronic wounds and surgical procedures globally.